Status:
COMPLETED
Network on Antimicrobial Resistance in Staphylococcus Aureus
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Staphylococcus Aureus
Eligibility:
All Genders
Brief Summary
Reduced susceptibility of Staphyloccus aureus to the glycopeptide antibiotic vancomycin is causing increasing concern worldwide in view of the threat of increased morbidity and mortality caused by suc...
Detailed Description
Reduced susceptibility of Staphyloccus aureus to the glycopeptide antibiotic vancomycin is causing increasing concern worldwide in view of the threat of increased morbidity and mortality caused by suc...
Eligibility Criteria
Inclusion
- INCLUSION AND EXCLUSION CRITERIA:
- This study is concerned with the collection of data on the antimicrobial phenotypes of bacterial isolates and not the patient(s) from which they were isolated. Therefore, criteria for the inclusion or exclusion of patients does not apply.
Exclusion
Key Trial Info
Start Date :
March 16 2000
Trial Type :
OBSERVATIONAL
End Date :
June 17 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00341913
Start Date
March 16 2000
End Date
June 17 2008
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MRL Pharmaceutical Services
Herndon, Virginia, United States, 20171-4603